Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Rationale and study design of a randomized clinical trial of metformin to prevent frailty in older adults with prediabetes
Latest KOL Views on GLP-1 agonists To keep up with current and future GLP-1 agonists market trends, we incorporate Key physicians, Therapy Area Researchers, and other Industry Experts opinions working in the domain through primary research to fill in the data gaps and validate our secondary research
To date, dulaglutide, semaglutide, and tirzepatide have been the three predominant GLP-1 therapeutics employed in the treatment of T2DM, and their applications have been broadened to include weight management
Speak with one of our healthcare specialists today to explore your options and find the right care plan for your goals
